Digital Biomarkers in Multiple Sclerosis
For incurable diseases, such as multiple sclerosis (MS), the prevention of progression and the preservation of quality of life play a crucial role over the entire therapy period. In MS, patients tend to become ill at a younger age and are so variable in terms of their disease course that there is no...
Guardado en:
Autores principales: | Anja Dillenseger, Marie Luise Weidemann, Katrin Trentzsch, Hernan Inojosa, Rocco Haase, Dirk Schriefer, Isabel Voigt, Maria Scholz, Katja Akgün, Tjalf Ziemssen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1cb983341f014702947ab3c2da14a9c5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Automated Analysis of the Two-Minute Walk Test in Clinical Practice Using Accelerometer Data
por: Katrin Trentzsch, et al.
Publicado: (2021) -
eHealth Literacy: From Theory to Clinical Application for Digital Health Improvement. Results from the ACCESS Training Experience
por: Roberta Bevilacqua, et al.
Publicado: (2021) -
Lymphocyte Counts and Multiple Sclerosis Therapeutics: Between Mechanisms of Action and Treatment-Limiting Side Effects
por: Stefanie Fischer, et al.
Publicado: (2021) -
Negative Impacts of COVID-19 Induced Lockdown on Changes in Eating Behavior, Physical Activity, and Mental Health as Modified by Digital Healthy Diet Literacy and eHealth Literacy
por: Tham T. Nguyen, et al.
Publicado: (2021) -
The effectiveness of digital interventions for increasing physical activity in individuals of low socioeconomic status: a systematic review and meta-analysis
por: Max J. Western, et al.
Publicado: (2021)